Scale -


  • Revenue is 232 Rs Cr; Annual Decline is -27 %; Continuous Decline over 3 years; in Bottom Quartile; 5 Year CAGR is -21 %
  • Ebitda is -14.14 Rs Cr; Annual Decline is -139 %; in Bottom Quartile
  • PBT is -6.75 Rs Cr; Annual Decline is -1114 %; in Bottom Quartile
  • PAT is -44.4 Rs Cr; Annual Decline is -761 %; in Bottom Quartile
  • Quarterly Revenue is 57.12 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is -6.09 %; Annual Decline is -153 %; in Bottom Quartile
  • PAT Margin is -19.12 %; Annual Decline is -1006 %; in Bottom Quartile
  • Quarterly Ebitda Margin is 2 %; in Bottom Quartile
  • Quarterly Profit margin is -13 %; in Bottom Quartile

Return -


  • ROCE is -27.33 %; Annual Decline is -343 %; in Bottom Quartile
  • ROA is -14.09 %; Annual Decline is -870 %; in Bottom Quartile
  • ROE is -43.08 %; Annual Decline is -1055 %; in Bottom Quartile
  • Asset Turnover is 68 %; Annual Decline is -25 %

Efficiency -


  • Operating cash flow is 4.18 Rs Cr; Annual Decline is -90 %; in Bottom Quartile
  • Current Ratio is 0.79; Continuous Decline over 3 years; in Bottom Quartile
  • Quick Ratio is 0.27; Continuous Decline over 3 years; in Bottom Quartile
  • Inventory Turnover Ratio is 1.92; in Bottom Quartile

Solvancy -


  • Contingent Liabilities is 10 Rs Cr; Annual Decline is -71 %
  • Long term Debt is 7.5 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is -25 %
  • Debt/Equity is 0.99; Annual Growth is 83 %; in Top Quartile; 5 Year CAGR is 23 %

Quality -


  • Current Tax/PAT is 0 %; Annual Decline is -100 %; in Bottom Quartile
  • Operating cashflow/ebitda is -30 %; Annual Decline is -125 %; in Bottom Quartile
  • Operating cashflow/PAT is -9 %; Annual Decline is -101 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 11 %; Annual Growth is 266 %; in Top Quartile; 5 Year CAGR is 118 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Mangalam Drugs and Organics (NSE:MANGALAM): Has the Company Defaulted on Bank Loans?
Mangalam Drugs And Organics Ltd Defaulted On Loan Obligations To Bank Of Baroda And Bank Of Maharashtra
Mangalam Drugs And Organics vs Nifty 50: Returns Compared